Inhibitors of JNK

Details for Australian Patent Application No. 2010283769 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Gong, Leyi; Han, Xiaochun; Makra, Ferenc; Palmer, Wylie Solang; Raptova, Lubica

Agent Spruson & Ferguson

Pub. Number AU-A-2010283769

PCT Pub. Number WO2011/018417

Priority 61/232,522 10.08.09 US

Filing date 6 August 2010

Wipo publication date 17 February 2011

International Classifications

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

9 February 2012 PCT application entered the National Phase

  PCT publication WO2011/018417 Priority application(s): WO2011/018417

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010283806-Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation

2010283767-Microbiocidal heterocycles